These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 25583658)

  • 21. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
    Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
    Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
    Siironen P; Hagström J; Mäenpää HO; Louhimo J; Heikkilä A; Heiskanen I; Arola J; Haglund C
    Oncology; 2010; 79(5-6):400-8. PubMed ID: 21455012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approach to the patient with anaplastic thyroid carcinoma.
    Smallridge RC
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2566-72. PubMed ID: 22869844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer.
    Riesco-Eizaguirre G; Galofré JC; Grande E; Zafón Llopis C; Ramón y Cajal Asensio T; Navarro González E; Jiménez-Fonseca P; Santamaría Sandi J; Gómez Sáez JM; Capdevila J
    Endocrinol Nutr; 2016 Apr; 63(4):e17-24. PubMed ID: 26601805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.
    Hamidi S; Dadu R; Zafereo ME; Ferrarotto R; Wang JR; Maniakas A; Gunn GB; Lee A; Spiotto MT; Iyer PC; Sousa LG; Akhave NS; Ahmed S; Learned KO; Lu C; Lai SY; Williams M; Hosseini SM; Busaidy NL; Cabanillas ME
    JAMA Oncol; 2024 Sep; 10(9):1264-1271. PubMed ID: 38990526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and Management of Anaplastic Thyroid Cancer.
    Chintakuntlawar AV; Foote RL; Kasperbauer JL; Bible KC
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):269-284. PubMed ID: 30717908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
    Ain KB
    Thyroid; 1998 Aug; 8(8):715-26. PubMed ID: 9737368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.
    Min IM; Shevlin E; Vedvyas Y; Zaman M; Wyrwas B; Scognamiglio T; Moore MD; Wang W; Park S; Park S; Panjwani S; Gray KD; Tassler AB; Zarnegar R; Fahey TJ; Jin MM
    Clin Cancer Res; 2017 Dec; 23(24):7569-7583. PubMed ID: 29025766
    [No Abstract]   [Full Text] [Related]  

  • 30. Poorly differentiated and anaplastic thyroid cancer.
    Patel KN; Shaha AR
    Cancer Control; 2006 Apr; 13(2):119-28. PubMed ID: 16735986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma.
    Higashiyama T; Ito Y; Hirokawa M; Fukushima M; Uruno T; Miya A; Matsuzuka F; Miyauchi A
    Thyroid; 2010 Jan; 20(1):7-14. PubMed ID: 20025538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
    Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery combined with adjuvant radiation and chemotherapy prolonged overall survival in stage IVC anaplastic thyroid cancer: a SEER-based analysis.
    Yin Y; Wang L; Huang C
    Endocrine; 2024 Jul; 85(1):250-257. PubMed ID: 38183567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
    Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD
    Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
    Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
    Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer.
    Li W; Li Y; Li J; Pang H
    Technol Cancer Res Treat; 2023; 22():15330338231169870. PubMed ID: 37122242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differential diagnosis and strategy for the treatment of anaplastic thyroid carcinoma].
    Suzuki S
    Nihon Rinsho; 2007 Nov; 65(11):2079-86. PubMed ID: 18018574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaplastic thyroid carcinoma: review of treatment protocols.
    Tiedje V; Stuschke M; Weber F; Dralle H; Moss L; Führer D
    Endocr Relat Cancer; 2018 Mar; 25(3):R153-R161. PubMed ID: 29295821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of anaplastic thyroid carcinoma in the Kurdistan region of Iraq.
    Mustafa DH; Ahmed BS; Haweizy RM; Dewana AM
    BMC Surg; 2022 Oct; 22(1):364. PubMed ID: 36271386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Personalized approach to anaplastic thyroid carcinoma].
    Wächter S; Bartsch DK; Maurer E
    Chirurgie (Heidelb); 2024 Mar; 95(3):192-199. PubMed ID: 37973622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.